Biocept, Inc. / Estimates

Fiscal Year	Revenue	Net income	Net margin	Free cash flow	FCF margin
2022	€22.28M -57.8%	-€27.64M +1,036.2%	-124.1% -1.2 pp	-€10.75M -337.2%	-48.3% -0.57 pp
2021	€52.77M +123.0%	-€2.43M -84.1%	-4.6% +0.60 pp	€4.53M -127.8%	8.6% +0.77 pp
2020	€23.66M +396.7%	-€15.34M -29.2%	-64.8% +3.9 pp	-€16.30M -15.2%	-68.9% +3.3 pp
2019	€4.76M	-€21.66M	-454.7%	-€19.22M	-403.6%